Results 211 to 220 of about 142,808 (332)
Nonsteroidal Antiinflammatory Drugs for Axial Spondyloarthritis: A Cochrane Review
F. Kroon +6 more
semanticscholar +1 more source
Abstract Aims The risk of diabetic nephropathy among patients with type 2 diabetes (T2D) can be reduced through optimal glycaemic control. It is not known if the pharmacological properties of long‐acting insulin analogues may reduce the risk of diabetic complications compared with neutral protamine Hagedorn (NPH) insulin.
Julia Brillinger +6 more
wiley +1 more source
Diabetic kidney disease, biomarkers, and finerenone
Abstract Diabetic kidney disease (DKD), the leading cause of kidney failure worldwide, is associated with an increased risk of cardiovascular disease (CVD). A complex pathobiology involving hemodynamic, metabolic, and immune dysregulation promotes inflammatory and fibrotic pathways that contribute to kidney disease progression and CVD in individuals ...
Ashish Verma, Ashish Upadhyay
wiley +1 more source
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival. [PDF]
Crown J +21 more
europepmc +1 more source
Nonsteroidal Antiinflammatory Drugs [PDF]
openaire +1 more source
Abstract Aims We investigated whether dipeptidyl peptidase‐4 inhibitor (DPP‐4i) use was associated with a higher risk of acute pancreatitis compared with sodium–glucose cotransporter 2 inhibitor (SGLT2i) use in antidiabetic medication‐naïve individuals.
Takashi Tatewaki +3 more
wiley +1 more source
Finerenone as a Nonsteroidal Mineralocorticoid Receptor Antagonist for Lupus Nephritis. [PDF]
Sun M, Xiao F, Chen X, Wang L, Dai H.
europepmc +1 more source

